Peptide Research Guides: BPC-157, TB-500, GHK-Cu & More

AOD-9604 mechanism of action showing beta-3 adrenergic receptor lipolysis pathway in adipocytes

AOD-9604 Mechanism of Action: How the hGH Fragment Works

A detailed scientific analysis of how AOD-9604 exerts its metabolic effects at the molecular level. Covers the beta-3 adrenergic receptor upregulation pathway confirmed by knockout mouse studies, the cAMP-HSL-ATGL lipolytic cascade in adipocytes, simultaneous lipogenesis inhibition, the critical independence from GH receptor and JAK2-STAT5 signaling, absence of IGF-1 stimulation and diabetogenic effects, preferential action on obese versus lean adipocytes, emerging chondroprotective mechanisms in cartilage tissue, and comparison with the lipolytic mechanisms of full-length human growth hormone, GLP-1 receptor agonists, and ERR exercise mimetics.

Mar 10, 2026 · 16 min read

AOD-9604 Mechanism of Action Beta-3 Adrenergic

AOD-9604 research guide covering hGH fragment mechanism clinical trials and FDA GRAS status

AOD-9604: Complete Research Guide for Scientists

A comprehensive scientific guide to AOD-9604, the modified C-terminal fragment (amino acids 176-191) of human growth hormone with an N-terminal tyrosine substitution. Covers the discovery at Monash University by Professor Frank Ng, the beta-3 adrenergic receptor mechanism of lipolysis and lipogenesis inhibition, the critical distinction from full hGH (no IGF-1 stimulation, no diabetogenic effects, no GH receptor binding), the complete clinical trial history from Metabolic Pharmaceuticals (six human trials, 900+ subjects), the Phase IIb OPTIONS trial outcome, FDA GRAS status as a food ingredient, emerging cartilage repair and chondroprotective research, WADA prohibition status, practical handling and storage guidance, and context within the metabolic research peptide landscape.

Mar 10, 2026 · 21 min read

AOD-9604 hGH Fragment Growth Hormone

GLP-1 side effects science covering gastrointestinal tolerability pancreatitis thyroid and safety data

GLP-1 Side Effects: The Science Behind Safety and Tolerance

A scientific review of the adverse effect profile of GLP-1 receptor agonists. Covers the pharmacological mechanisms behind gastrointestinal side effects (nausea, vomiting, diarrhea, constipation), dose-titration strategies and tachyphylaxis, the pancreatitis question (FAERS signals vs RCT meta-analyses), gallbladder events and cholelithiasis risk from rapid weight loss, thyroid C-cell concerns (rodent data vs human evidence, FDA boxed warning context), perioperative aspiration risk and ASA guidance on gastric retention, muscle mass loss considerations, retinopathy signals, the January 2026 FDA removal of suicidal ideation warning, and how dual agonists like GLP dual agonist peptide may modulate GI tolerability through imbalanced receptor engagement.

Mar 10, 2026 · 18 min read

GLP-1 Side Effects Safety

GLP-1 beyond weight loss covering cardiovascular renal liver and brain research applications

GLP-1 Beyond Weight Loss: Heart, Kidney, Liver, and Brain Research

An evidence-based review of GLP-1 receptor agonist research beyond diabetes and obesity. Covers cardiovascular protection (SELECT 20% MACE reduction, LEADER, SUSTAIN-6), heart failure with preserved ejection fraction (SUMMIT trial, GLP dual agonist peptide 38% risk reduction), renal protection (FLOW trial, 24% kidney composite risk reduction, FDA CKD approval), metabolic liver disease (MASH FDA approval for GLP-1 agonist peptide, 63% resolution at 72 weeks), neurodegeneration (Alzheimer's and Parkinson's preclinical data, 48% dementia risk reduction in cohort studies, exenatide-PD3 Phase 3 outcome), addiction and substance use disorders, and the emerging multi-organ therapeutic paradigm.

Mar 10, 2026 · 20 min read

GLP-1 Cardiovascular Kidney

Oral vs injectable GLP-1 agonists formulation science comparing SNAC semaglutide and orforglipron

Oral vs Injectable GLP-1 Agonists: Formulation Science and Clinical Data

A scientific comparison of oral and injectable GLP-1 receptor agonist formulations. Covers the fundamental barriers to oral peptide delivery, SNAC absorption enhancer technology behind oral GLP-1 agonist peptide (Rybelsus), the bioavailability gap (0.8% oral vs near-complete subcutaneous absorption), dosing restrictions and their pharmacological rationale, high-dose oral GLP-1 agonist peptide (25-50 mg OASIS program), the paradigm shift to non-peptide small-molecule oral GLP-1 agonists (orforglipron Phase 3 ATTAIN data showing 12.4% weight loss at 36 mg), the ATTAIN-Maintain weight maintenance trial, and implications for peptide research and drug delivery.

Mar 10, 2026 · 19 min read

GLP-1 Oral GLP-1 agonist Orforglipron

GLP-1 receptor agonists science guide covering mechanism semaglutide tirzepatide and multi-agonists

GLP-1 Receptor Agonists: How They Work and Why They Matter

A comprehensive scientific guide to GLP-1 receptor agonists — the drug class that has transformed the treatment of type 2 diabetes and obesity. Covers the incretin effect and GLP-1 biology, receptor signaling through cAMP-PKA and PI3K-Akt pathways, central and peripheral mechanisms of appetite suppression and weight loss, the evolution from exenatide to GLP-1 agonist peptide to GLP dual agonist peptide, dual and triple agonist pharmacology, cardiovascular and renal protective effects, emerging applications in neurodegeneration and addiction, the GI tolerability profile, and the pipeline of next-generation multi-agonists including oral formulations.

Mar 10, 2026 · 22 min read

GLP-1 Receptor Agonist GLP-1 agonist

Signs a peptide has degraded showing visual analytical and functional indicators for researchers

Signs a Peptide Has Degraded: Visual, Analytical, and Functional Indicators

A practical guide for researchers to identify peptide degradation through visual inspection, analytical testing, and functional assessment. Covers observable indicators in lyophilized and reconstituted forms, HPLC and mass spectrometry signatures of common degradation products, unexpected experimental results that may indicate compromised peptide integrity, and decision frameworks for when to discard stored material versus when to continue using it.

Mar 9, 2026 · 14 min read

Peptide Degradation Quality Assessment HPLC

Peptide shelf life after reconstitution showing storage timelines and aliquoting strategies

Peptide Shelf Life After Reconstitution: Timelines, Storage, and Stability Factors

A practical guide to how long reconstituted peptides remain stable and usable under various storage conditions. Covers stability timelines at room temperature, refrigerated, and frozen storage, the effects of solvent choice and pH on reconstituted stability, sequence-dependent factors that shorten reconstituted shelf life, aliquoting strategies to maximize usable lifetime, signs of degradation in reconstituted solutions, and when to discard reconstituted material.

Mar 9, 2026 · 13 min read

Reconstituted Peptides Shelf Life Storage

Oxidation in synthetic peptides showing susceptible residues mechanisms and prevention strategies

Oxidation in Synthetic Peptides: Susceptible Residues, Mechanisms, and Prevention

A detailed scientific guide to oxidative degradation in synthetic peptides. Covers the susceptibility hierarchy of amino acid residues to oxidation, the specific oxidation products formed from cysteine, methionine, tryptophan, histidine, and tyrosine, the distinction between site-specific metal-catalyzed oxidation and non-specific reactive oxygen species damage, photodegradation pathways, practical prevention strategies including inert gas overlay and antioxidant excipients, and methods for detecting oxidation products by HPLC and mass spectrometry.

Mar 9, 2026 · 14 min read

Peptide Oxidation Methionine Cysteine

Moisture and peptide degradation showing hydrolysis mechanisms humidity control and desiccation strategies

Moisture and Peptide Degradation: Hydrolysis, Humidity Control, and Desiccation Strategies

A detailed examination of how moisture drives peptide degradation in both lyophilized and solution states. Covers water as a reactant in hydrolysis, the plasticizing effect of residual moisture on lyophilized matrices, humidity-driven moisture uptake, condensation prevention during vial handling, desiccant strategies, Karl Fischer moisture testing, and practical protocols for maintaining dry conditions throughout the peptide storage and handling workflow.

Mar 9, 2026 · 13 min read

Moisture Peptide Degradation Hydrolysis

Temperature effects on peptide stability showing thermal degradation cold chain and storage optimization

Temperature Effects on Peptides: Thermal Degradation, Cold Chain, and Storage Optimization

A detailed analysis of how temperature affects peptide stability across the entire range from ultra-cold storage through room temperature and elevated thermal stress. Covers Arrhenius kinetics applied to peptide degradation, the critical role of glass transition temperature in lyophilized formulations, freeze-thaw cycle damage mechanisms, cold chain requirements for shipping, frost-free freezer risks, and practical temperature management protocols for research laboratories.

Mar 9, 2026 · 13 min read

Temperature Peptide Stability Arrhenius

Factors affecting peptide stability including sequence composition temperature moisture and pH

Factors That Affect Peptide Stability: Sequence, Environment, and Formulation

A comprehensive analysis of all factors that influence peptide stability in research settings. Covers intrinsic factors including amino acid composition, sequence motifs, peptide length, and modifications. Examines extrinsic factors including temperature, pH, moisture, oxygen, light, ionic strength, buffer selection, container materials, and handling practices. Provides a practical framework for predicting which peptides will require the most careful handling based on their sequence.

Mar 9, 2026 · 14 min read

Peptide Stability Degradation Factors Oxidation

Research Articles